Hanmi to launch dexibuprofen syrup from next month

Hanmi Pharm said its independently developed Maxibufen (dexibuprofen) syrup, an analgesic and antipyretic agent, will be available from January 2007.

Half dose of Maxibufen syrup has proven at least comparable efficacy to the full dose of ibuprofen syrup even in a 50-percent dose, with less nephrotoxicity and hepatotoxicity. Currently, dexibuprofen for oral solid administration is available ...